Clinical Trial Update: Effects of Metformin on Hepatic FFA Metabolism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of metformin on hepatic free fatty acid metabolism in adults with type 2 diabetes and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Lars Christian Gormsen | Conditions: Type 2 Diabetes, Dyslipidemia | Phase 4 | Status: COMPLETED | Results posted: 2019-10-15